Alpine Immune Sciences, Inc. announced that members of its management team will participate at the following investor conferences in May 2022: LifeSci Partners Immunology & Inflammation Symposium Date: Tuesday, May 10, 2022 Time: 3:00 p.m. ET/12:00 p.m.
LifeSci Partners Immunology & Inflammation Symposium
Date: Tuesday, May 10, 2022
Time: 3:00 p.m. ET/12:00 p.m. PT
Event: Fireside Chat
BofA Securities Healthcare Conference 2022
Date: Wednesday, May 11, 2022
Time: 7:15 p.m. ET/4:15 p.m. PT
Event: Corporate Presentation
Webcasts of the LifeSci Partners fireside chat and BofA corporate presentation will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the fireside chats will be available on the company website for 90 days following the webcast.
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220503005586/en/
Investor Relations
Alex Sharif
Director, Investor Relations and Corporate Development
Alpine Immune Sciences, Inc
206-788-4545
ir@alpineimmunesciences.com
Media Relations
Kelli Perkins
Red House
Kelli@redhousecomms.com
Source: Alpine Immune Sciences, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20220503005586/en